通过CD137L连接介导的来自半相合异基因相关供体的间充质干细胞移植后，严重进行性系统性硬化症有显著改善。 - Suppr

Suppr

超能文献

Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L.

作者信息

Christopeit M, Schendel M, Föll J, Müller L P, Keysser G, Behre G

出版信息

Leukemia. 2008 May;22(5):1062-4. doi: 10.1038/sj.leu.2404996. Epub 2007 Nov 1.

DOI:10.1038/sj.leu.2404996

PMID:17972956

Abstract

摘要

相似文献

Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L.通过CD137L连接介导的来自半相合异基因相关供体的间充质干细胞移植后，严重进行性系统性硬化症有显著改善。

Leukemia. 2008 May;22(5):1062-4. doi: 10.1038/sj.leu.2404996. Epub 2007 Nov 1.

Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases.采用来自同种异体相关供体的间充质基质细胞移植治疗重度进行性系统性硬化症：5例报告

Arthritis Rheum. 2011 Aug;63(8):2540-2. doi: 10.1002/art.30431.

Severe acute graft-versus-host disease after T-cell depleted allogeneic stem cell graft from a second donor caused by persisting T-cells from the first donor.来自首个供体的持续T细胞导致二次供体的T细胞去除同种异体干细胞移植后发生严重急性移植物抗宿主病。

Bone Marrow Transplant. 2003 Sep;32(5):511-3. doi: 10.1038/sj.bmt.1704170.

Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis.同种异体间充质干细胞移植治疗多发性硬化症。

Mult Scler. 2009 May;15(5):644-6. doi: 10.1177/1352458509104590.

Rapid induction of CD95 ligand and CD4+ T cell-mediated apoptosis by CD137 (4-1BB) costimulation.通过CD137（4-1BB）共刺激快速诱导CD95配体和CD4 + T细胞介导的细胞凋亡。

Eur J Immunol. 2001 May;31(5):1410-6. doi: 10.1002/1521-4141(200105)31:5<1410::AID-IMMU1410>3.0.CO;2-H.

Expression of CD137 and CD137 ligand in colorectal cancer patients.CD137与CD137配体在结直肠癌患者中的表达

Oncol Rep. 2006 May;15(5):1197-200.

Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.在同种异体移植工程中，使用患者来源的非造血刺激细胞选择性清除同种异体反应性T淋巴细胞。

Transplantation. 2008 Nov 27;86(10):1427-35. doi: 10.1097/TP.0b013e31818810d6.

Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.阻断4-1BB（CD137）/4-1BB配体相互作用可提高同种异体移植物的存活率。

Transpl Int. 2004 Aug;17(7):351-61. doi: 10.1007/s00147-004-0726-3. Epub 2004 Jul 31.

Clin Transpl. 2011:237-45.

Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.多能间充质基质细胞在异基因干细胞移植后儿科患者中的应用。

Blood Cells Mol Dis. 2008 Jan-Feb;40(1):25-32. doi: 10.1016/j.bcmd.2007.06.021. Epub 2007 Sep 14.

引用本文的文献

The therapeutic efficacy of mesenchymal stem cells and their extracellular vesicles in the treatment of diverse skin diseases.间充质干细胞及其细胞外囊泡在治疗多种皮肤病中的疗效。

Front Immunol. 2025 Aug 19;16:1626066. doi: 10.3389/fimmu.2025.1626066. eCollection 2025.

Mesenchymal Stem-Cell-Derived Exosomes and MicroRNAs: Advancing Cell-Free Therapy in Systemic Sclerosis.间充质干细胞衍生的外泌体与微小RNA：推动系统性硬化症的无细胞治疗

Cells. 2025 Jul 3;14(13):1018. doi: 10.3390/cells14131018.

Stem cell therapy in systemic sclerosis.系统性硬化症中的干细胞疗法。

Clin Rheumatol. 2025 Jul 2. doi: 10.1007/s10067-025-07557-y.

Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases-systemic sclerosis and sclerodermatous graft-versus-host disease.基于间充质干细胞的治疗方法用于治疗自身免疫性相关的纤维性皮肤病——系统性硬化症和硬皮病移植物抗宿主病。

Stem Cell Res Ther. 2023 Dec 18;14(1):372. doi: 10.1186/s13287-023-03543-w.

Stem cell-based therapy for systemic sclerosis.基于干细胞的系统性硬化症治疗

Rheumatol Adv Pract. 2023 Nov 20;7(3):rkad101. doi: 10.1093/rap/rkad101. eCollection 2023.

Progress in research on mesenchymal stem cells and their extracellular vesicles for treating fibrosis in systemic sclerosis.间充质干细胞及其细胞外囊泡治疗系统性硬化症纤维化的研究进展

Clin Exp Med. 2023 Nov;23(7):2997-3009. doi: 10.1007/s10238-023-01136-8. Epub 2023 Jul 17.

Mesenchymal Stem/Stromal Cell-Based Therapies in Systemic Rheumatic Disease: From Challenges to New Approaches for Overcoming Restrictions.基于间充质干细胞/基质细胞的系统性风湿病治疗：从挑战到克服限制的新方法。

Int J Mol Sci. 2023 Jun 15;24(12):10161. doi: 10.3390/ijms241210161.

Umbilical-Cord-Derived Mesenchymal Stromal Cells Modulate 26 Out of 41 T Cell Subsets from Systemic Sclerosis Patients.脐带间充质基质细胞调节系统性硬化症患者41个T细胞亚群中的26个。

Biomedicines. 2023 Apr 30;11(5):1329. doi: 10.3390/biomedicines11051329.

The role of TNF-α in the fate regulation and functional reprogramming of mesenchymal stem cells in an inflammatory microenvironment.肿瘤坏死因子-α在炎症微环境中对间充质干细胞命运调控和功能重编程的作用。

Front Immunol. 2023 Feb 6;14:1074863. doi: 10.3389/fimmu.2023.1074863. eCollection 2023.

Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches.系统性硬化症的细胞治疗：从造血干细胞移植到创新方法。

Cells. 2022 Oct 24;11(21):3346. doi: 10.3390/cells11213346.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验